期刊文献+

GLP-2对SAP大鼠肠黏膜屏障的保护作用 被引量:2

Protective effects of GLP-2 on intestinal mucosal barrier in rats with severe acute pancreatitis
下载PDF
导出
摘要 目的探讨胰高血糖素样肽-2(GLP-2)在重症急性胰腺炎(SAP)肠黏膜屏障中的保护作用。方法 SD大鼠30只,随机分为3组:假手术组、SAP组、GLP-2组。采用胰管逆行注射3%牛磺胆酸钠溶液制作SAP模型。GLP-2组在制作SAP模型后,皮下注射GLP-2 0.1mg/kg,连续注射3d。3d后处死大鼠。透射电子显微镜观察小肠黏膜改变,检测各组血浆二胺氧化酶(DAO)及内毒素(ET)水平。结果 SAP组大鼠小肠黏膜出现明显病理损害;与SAP组相比较,GLP-2组小肠黏膜损伤显著减轻。SAP组DAO及ET水平明显高于假手术组(P<0.05);与SAP组比较,GLP-2组DAO及ET水平明显低于SAP组(P<0.05)。结论 GLP-2对SAP大鼠肠黏膜屏障功能具有一定保护作用。 Objective To explore the protective effects of glucagon like peptide-2(GLP-2) on intestinal mucosal barrier in rats with severe acute pancreatitis(SAP).Methods 30 rats were randomly divided into 3 groups:control group(sham operation group),severe acute pancreatitis model group(SAP group),GLP-2 group(SAP rats treated with GLP-2).The SAP rat models were established via retrograde injection of 3% sodium taurocholate to the pancreatic duct.Rats in GLP-2 group were peritoneally injected with GLP-2 with dose of 0.1 mg/kg per day for 3 days.Three days later,the severity of intestinal mucosal damage was investigated by transmission electron microscope(TEM).Plasma concentration of diamine oxidas(DAO) and entotoxin(ET) in each rat were determined.Results Compared with control group,the intestinal mucosa of rats in SAP group injured significantly.GLP-2 treatment attenuated AP-induced mucosal injury.Compared with control group,the concentration of DAO and ET in SAP group increased significantly(P0.05);Compared with SAP group,the concentration of DAO and ET in GLP-2 group decreased significantly(P0.05).Conclusion GLP-2 has a protective effects on intestinal barrier in rats with severe acute pancreatitis.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第31期3127-3128,3131,F0002,共4页 Chongqing medicine
基金 四川省卫生厅科研课题(070267)
关键词 胰高血糖素样肽-2 肠黏膜 胺氧化酶 内毒素 glucagon like peptide-2 intestinal mucosal amine oxidase endotoxins
  • 相关文献

参考文献3

二级参考文献49

共引文献24

同被引文献25

  • 1Cameron H L,Perdue M H. Stress impairs murine intestinal barrier function:improvement by glucagon-like peptide-2[J].Journal of Pharmacology and Experimental Therapeutics,2005,(01):214-220.doi:10.1124/jpet.105.085373.
  • 2Cameron H L,Yang P C,Perdue M H. Glucagon-like peptide2-enhanced barrier function reduces pathophysiology in a model of food allergy[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2003,(06):G905-G912.
  • 3Meier J J,Nauck M A,Pott A. Glucagon-like peptide 2 stimulates glucagon secretion,enhances lipid absorption,and inhibits gastric acid secretion in humans[J].Gastroenterology,2006,(01):44-54.
  • 4Schierack P,Nordhoff M,Pollmann M. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesisin swine[J].Histochemistry and Cell Biology,2006,(03):293-305.
  • 5Pfaffl M W. A new mathematical model for relative quantification in real-time RT-PCR[J].Nucleic Acids Research,2001,(09):e45.
  • 6Petersen Y M,Elnif J,Schmidt M. Glucagon-like peptide 2 enhances maltase-glucoamylase and sucrase-isomaltase gene expression and activity in parenterally fed premature neonatal piglets[J].Pediatric Research,2002,(04):498-503.
  • 7Burrin D G,Stoll B,Guan X. GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets[J].American Journal of Physiology Endocrinology and Metabolism,2007,(01):E281-E291.
  • 8Brubaker P L,Crivici A,Izzo A. Circulating and tissue forms of the intestinal growth factor,glucagon-like peptide-2[J].Endocrinology,1997,(11):4837-4843.
  • 9Guan X,Karpen H E,Stephens J. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow[J].Gastroenterology,2006,(01):150-164.
  • 10Bremholm L,Hornum M,Henriksen BM. Glucagon-like peptide-2 increases mesenteric blood flow in humans[J].Scandinavian Journal of Gastroenterology,2009,(03):314-319.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部